What is the recommended dosage of Megace (megestrol acetate) for appetite stimulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Megestrol Acetate for Appetite Stimulation

The recommended dosage of megestrol acetate for appetite stimulation is 800 mg/day (20 mL/day), as indicated by the FDA label. 1

Evidence-Based Dosing Recommendations

Megestrol acetate is a well-established appetite stimulant with multiple dosing options supported by clinical evidence:

  • FDA-approved dosage: 800 mg/day (20 mL/day) is the recommended adult initial dosage 1
  • Effective dose range: Clinical trials have found both 400 mg/day and 800 mg/day to be clinically effective 1
  • National Comprehensive Cancer Network: Recommends 400-800 mg/day for cancer-related anorexia/cachexia 2
  • Alternative dosing: Some evidence supports lower doses of 80 mg twice daily (160 mg/day) as an appropriate starting dose for anorexia in advanced cancer 3

Dosing Algorithm

  1. Initial dosing: Start with 800 mg/day (20 mL/day) for most patients with significant appetite loss
  2. Alternative initial dosing: Consider 400 mg/day for elderly patients or those at higher risk for side effects
  3. Administration: Shake container well before using; can be divided into multiple daily doses
  4. Monitoring: Assess response after 2-4 weeks
  5. Dose adjustment:
    • If ineffective at initial dose, consider dose escalation (up to 800 mg/day if started lower)
    • If side effects occur, consider dose reduction
    • Discontinue if no benefit after 4 weeks of therapy

Efficacy and Clinical Considerations

Megestrol acetate has demonstrated significant benefits for appetite stimulation:

  • Improves appetite and food intake in patients with cancer-associated anorexia 4
  • Can lead to significant weight gain in a proportion of patients 4
  • Shows dose-dependent improvements in nutritional markers like prealbumin 5
  • Reduces nausea and vomiting in some patients 4

Important Side Effects and Monitoring

When prescribing megestrol acetate, monitor for:

  • Thromboembolic events: Significant risk (relative risk 1.84) 2
  • Fluid retention/edema: Common side effect (relative risk 1.36) 2
  • Adrenal suppression: Dose-dependent cortisol suppression occurs frequently, especially at higher doses 5
  • Weight gain: Both beneficial (muscle/fat) and potentially problematic (fluid) 2, 4

Special Populations

  • Elderly patients: Consider starting at 400 mg/day, as studies show efficacy at this dose with potentially fewer side effects 5
  • Dialysis patients: 400 mg/day has shown benefits for malnutrition-inflammation complex without major side effects 6

Clinical Pitfalls to Avoid

  • Indefinite use: Discontinue if ineffective after 4 weeks rather than continuing indefinitely 2
  • Failure to monitor: Regular weight checks and nutritional status assessment are essential
  • Ignoring side effects: Monitor for thromboembolic events, adrenal insufficiency, and fluid retention
  • Missing contraindications: Use caution in patients with history of thromboembolism or severe fluid retention

Megestrol acetate remains one of the most effective pharmacological interventions for appetite stimulation, with the strongest evidence supporting doses of 400-800 mg/day.

References

Guideline

Management of Anorexia of Aging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.